184 related articles for article (PubMed ID: 19878212)
21. Alprazolam reduces stress hyperglycemia in ob/ob mice.
Surwit RS; McCubbin JA; Kuhn CM; McGee D; Gerstenfeld D; Feinglos MN
Psychosom Med; 1986; 48(3-4):278-82. PubMed ID: 2871583
[TBL] [Abstract][Full Text] [Related]
22. Rhizoma Anemarrhenae extract ameliorates hyperglycemia and insulin resistance via activation of AMP-activated protein kinase in diabetic rodents.
Han J; Yang N; Zhang F; Zhang C; Liang F; Xie W; Chen W
J Ethnopharmacol; 2015 Aug; 172():368-76. PubMed ID: 26162543
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
Ueta K; Ishihara T; Matsumoto Y; Oku A; Nawano M; Fujita T; Saito A; Arakawa K
Life Sci; 2005 Apr; 76(23):2655-68. PubMed ID: 15792833
[TBL] [Abstract][Full Text] [Related]
24. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
[TBL] [Abstract][Full Text] [Related]
25. Des-aspartate-angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetic KKAy mice and GK rats.
Sim MK; Xu XG; Wong YC; Sim SZ; Lee KO
Endocrinology; 2007 Dec; 148(12):5925-32. PubMed ID: 17823251
[TBL] [Abstract][Full Text] [Related]
26. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats.
Jeppesen PB; Gregersen S; Alstrup KK; Hermansen K
Phytomedicine; 2002 Jan; 9(1):9-14. PubMed ID: 11924770
[TBL] [Abstract][Full Text] [Related]
27. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
[TBL] [Abstract][Full Text] [Related]
28. Acute and chronic administration of SHR117887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models.
Liu X; Zhang LN; Feng Y; Zhang L; Qu H; Cao GQ; Leng Y
Acta Pharmacol Sin; 2012 Aug; 33(8):1013-22. PubMed ID: 22842733
[TBL] [Abstract][Full Text] [Related]
29. Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice.
Son MJ; Minakawa M; Miura Y; Yagasaki K
Eur J Nutr; 2013 Sep; 52(6):1607-19. PubMed ID: 23238530
[TBL] [Abstract][Full Text] [Related]
30. Gastric Sleeve Surgery Alleviates Obesity-Associated Insulin Resistance and Suppresses Endoplasmic Reticulum Stress in Adipose Tissue of db/db Mice.
Sun M; Zhao W; Li S; Li C; Feng Y; Geng D
Obes Surg; 2019 Oct; 29(10):3220-3227. PubMed ID: 31197603
[TBL] [Abstract][Full Text] [Related]
31. Salidroside contributes to reducing blood pressure and alleviating cerebrovascular contractile activity in diabetic Goto-Kakizaki Rats by inhibition of L-type calcium channel in smooth muscle cells.
Ma YG; Wang JW; Bai YG; Liu M; Xie MJ; Dai ZJ
BMC Pharmacol Toxicol; 2017 Apr; 18(1):30. PubMed ID: 28441970
[TBL] [Abstract][Full Text] [Related]
32. Amarogentin ameliorates diabetic disorders in animal models.
Niu HS; Chao PC; Ku PM; Niu CS; Lee KS; Cheng JT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1215-1223. PubMed ID: 27485449
[TBL] [Abstract][Full Text] [Related]
33. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.
Standaert ML; Sajan MP; Miura A; Kanoh Y; Chen HC; Farese RV; Farese RV
J Biol Chem; 2004 Jun; 279(24):24929-34. PubMed ID: 15069067
[TBL] [Abstract][Full Text] [Related]
34. Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats.
Nayak Y; Hillemane V; Daroji VK; Jayashree BS; Unnikrishnan MK
ScientificWorldJournal; 2014; 2014():854267. PubMed ID: 25548795
[TBL] [Abstract][Full Text] [Related]
35. Syzygium cumini ameliorates insulin resistance and β-cell dysfunction via modulation of PPAR, dyslipidemia, oxidative stress, and TNF-α in type 2 diabetic rats.
Sharma AK; Bharti S; Kumar R; Krishnamurthy B; Bhatia J; Kumari S; Arya DS
J Pharmacol Sci; 2012; 119(3):205-13. PubMed ID: 22786584
[TBL] [Abstract][Full Text] [Related]
36. Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.
Niu HS; Ku PM; Niu CS; Cheng JT; Lee KS
Drug Des Devel Ther; 2015; 9():5625-32. PubMed ID: 26508837
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats.
Gao W; Bihorel S; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):143-62. PubMed ID: 21127951
[TBL] [Abstract][Full Text] [Related]
38. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats.
Shu XS; Lv JH; Tao J; Li GM; Li HD; Ma N
J Ethnopharmacol; 2009 Jul; 124(3):539-43. PubMed ID: 19454312
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
[TBL] [Abstract][Full Text] [Related]
40. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
